Seasoned pharma veteran joins INC Research
By Mia Burns (firstname.lastname@example.org)
INC Research, LLC, a therapeutically focused global clinical research organization with a Trusted Process for delivering reliable results, has announced James Taylor has joined the company as VP, clinical development. Taylor joins INC Research from Pfizer, where he served most recently as VP, global clinical trial management. In his new role, Taylor will serve as the primary liaison to biopharmaceutical customers, vendors and investigative sites for the company’s general medicine business unit.
“As more and more clinical development work has shifted to the CRO industry, quite a bit of senior level talent has migrated from big pharma to the CRO space as well, so it is quite common to hire senior talent with an extensive pharma background,” says INC Research COO Alistair Macdonald. “Customers want a CRO partner that understands the intricacies of their business, so it is natural to bring in employees, especially in leadership positions, with firsthand experience within biopharmaceutical companies.”
Taylor has more than 25 years of experience in the life sciences industry, including 15 years overseeing and executing global clinical trials. He also brings significant functional expertise in CRO selection and start-up, investigative site performance and contracting, CRO oversight and risk management, and alliance management from his experience at Pfizer where he oversaw the design, planning, and execution of late stage clinical trials. Mr. Taylor’s experience also includes serving as global head of outsourcing management at Sanofi-Aventis, where he was responsible for driving the global outsourcing strategy for its drug innovation and approval business unit.
“Strengthening our relationships with customers has always been a key focus,” Macdonald told R&D Pharma Business Connect. “We do this by bringing on talented individuals who continually think of new and better ways of delivering solutions that drive efficiencies throughout the drug development process and closely collaborate with customers to best anticipate and meet their evolving needs. Our relationships are further strengthened through innovative partnership models, which are structured so that we both share in the risks and rewards. Because we live and breathe our customers’ world, we truly understand their goals and challenges. By anticipating these challenges and offering a wide range of options for how to best deal with them, we’re able to do a better job of meeting their evolving needs, which enables true partnerships to form. Ultimately, we want to be such an integral part of customers’ teams that they wouldn’t even think of doing business anywhere else.”
Posted: October 2013